Clinical Trial: Effect of Telitacicept on Antibody Titers in Primary APS Patients
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Antiphospholipid Syndrome (APS)
Study Type: INTERVENTIONAL
Official Title: A Single Center, Randomized Controlled, Open Label Trial Exploring the Regulatory Effect of Telitacicept on Antibody Titers in Primary Antiphospholipid Syndrome Patients Carrying High-risk Antiphospho
Brief Summary:
The purpose of this study is to evaluate the regulatory effect of Telitacicept on antibody titers in primary antiphospholipid syndrome patients carrying high-risk antiphospholipid antibody profiles.
Read more